GlassScriptPhysician profile
Stephen F Lewis
NPI 1942289566
$5,935.38
in general payments reported to CMS, 2019-2025
42 companies · $946 in 2025
The $946 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,094 · 2020: $966 · 2021: $1,044 · 2022: $720 · 2023: $677 · 2024: $489 · 2025: $946.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,812 · Consulting Fee: $300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,812.18 |
| Consulting Fee | $300.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $937.38 | 2019-2025 | Tysabri, Vumerity, Leqembi |
| Ucb, INC. | $814.46 | 2019-2025 | Fintepla, Briviact |
| Sk Life Science, INC. | $631.34 | 2020-2025 | |
| Abbvie INC. | $364.00 | 2021-2025 | |
| Neurocrine Biosciences, INC. | $282.21 | 2019-2025 | Ingrezza, Ongentys |
| Strongbridge US INC. | $279.04 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $269.59 | 2019-2023 | Austedo |
| Ani Pharmaceuticals, INC. | $233.72 | 2022-2025 | Purified Cortrophin Gel |
| Eisai INC. | $231.72 | 2019-2024 | |
| Emd Serono, INC. | $185.39 | 2019-2023 | Mavenclad |
| Pfizer INC. | $173.54 | 2023-2025 | |
| Csl Behring | $157.65 | 2019-2025 | Hizentra |
| Allergan, INC. | $123.68 | 2019-2020 | |
| Xeris Pharmaceuticals, INC. | $100.16 | 2021-2023 | Keveyis |
| Genzyme Corporation | $93.05 | 2019-2022 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Lewis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.